DuPont Announces Price Increase for Ion Exchange Resins
January 31, 2022
Prices support supply reliability in face of rising production and shipping costs WILMINGTON, Del. -- DuPont (NYSE:DD) today announced an up to 15 percent price increase for products across its ion exchange resin portfolio, effective February 1, 2022 as local regulations and contracts allow. The new prices enable DuPont to provide customers with a reliable supply while [...]
January 31, 2022
VIENNA -- Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from Lansdowne Partners, Helicase Venture as well as several undisclosed investors. Existing investors IST cube and tecnet equity [...]
Lightsense Technology and Carahsoft Join Together to Bring “DrugDetect” to Government Agencies
January 31, 2022
Enabling US Law Enforcement with New Illicit Drug Detection Technology & Devices TUSCON, Az. and RESTON, Va. — Lightsense Technology, a pioneer of developing multi-spectroscopic solutions to address large problems in public health — from the opioid crisis to the pandemic, food safety and quality assurance in various supply chains — and Carahsoft Technology Corp., [...]
January 31, 2022
Vancouver – British Columbia, January 31, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT) (CNSX:LEXT.CN) (OTCQB:LEXTF) a biotechnology company focused on the development of analytical services and production of botanically derived psychedelics, is pleased to announce that, on January 17, 2022, its wholly-owned subsidiary, Egret Bioscience Ltd., was granted a two year long [...]
January 31, 2022
Marlborough, MA – Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements. Scitara joins BioPhorum Information Technology, whose mission is to accelerate digital maturity across the global biomanufacturing industry. One of the programs within the [...]
Leica Microsystems ready to welcome researchers at EMBL Imaging Centre
January 31, 2022
Wetzlar, Germany. Leica Microsystems, a leading manufacturer of microscopes and scientific instruments, has announced the opening of the new laboratories within the all new Imaging Centre at the European Molecular Biology Laboratory (EMBL) in Heidelberg. The state-of-the-art imaging centre will serve as an important hub to drive collaborative research. “The new Imaging Centre is a [...]
Xylem Appoints Mark Morelli to Board of Directors
January 31, 2022
RYE BROOK, N.Y. -- Global water technology leader, Xylem (NYSE:XYL), today announced the appointment of Mark Morelli to the Company’s Board of Directors, effective February 3, 2022. Mr. Morelli currently serves as President and CEO of Vontier Corporation, the $3B global industrial technology company focused on smarter mobility. He brings nearly two decades of experience [...]
Bio-Rad Launches Anti-Pertuzumab Antibodies
January 31, 2022
HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced four inhibitory antibodies that are highly specific to pertuzumab (Perjeta). These ready-made antibodies inhibit the binding of the drug to its target, human epidermal growth factor 2 (HER2), enabling researchers to develop [...]
January 29, 2022
In addition to Anton Paar's 100th anniversary, a subsidiary is also celebrating a major birthday this year – Anton Paar Italia turns ten. On the occasion of the anniversary celebration, the team plans a special project, as General Manager Fabrizio Scoffone explains: "In 2022, a tree will be planted for every instrument we sell. This will [...]
HTG Appoints Biopharmaceutical Industry Veteran Christopher Kiritsy to its Board of Directors
January 28, 2022
Brings Significant Operational Experience in Building Therapeutic Drug Development Businesses TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed biopharmaceutical industry veteran Christopher Kiritsy to its Board of Directors. Currently the Managing Member of Precision Kapital, LLC, a private [...]
